Current paradigms in the management of inflammatory bowel disease.
作者信息
Travis Simon
机构信息
Kennedy Institute of Rheumatology, Translational Gastroenterology and Liver Unit, NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
出版信息
Singapore Med J. 2025 Aug 1;66(8):413-415. doi: 10.4103/singaporemedj.SMJ-2025-078. Epub 2025 Aug 20.
Abstract
摘要
相似文献
1
Current paradigms in the management of inflammatory bowel disease.炎症性肠病管理的当前范式。
Singapore Med J. 2025 Aug 1;66(8):413-415. doi: 10.4103/singaporemedj.SMJ-2025-078. Epub 2025 Aug 20.
2
Structure and content components of self-management interventions that improve health-related quality of life in people with inflammatory bowel disease: a systematic review, meta-analysis and meta-regression.改善炎症性肠病患者健康相关生活质量的自我管理干预措施的结构和内容组成部分：一项系统评价、荟萃分析和荟萃回归分析
J Clin Nurs. 2015 Oct;24(19-20):2695-709. doi: 10.1111/jocn.12851. Epub 2015 Aug 12.
3
Management of Clostridium difficile Infection in Inflammatory Bowel Disease: Expert Review from the Clinical Practice Updates Committee of the AGA Institute.炎症性肠病中艰难梭菌感染的管理：AGA 研究所临床实践更新委员会的专家评论。
Clin Gastroenterol Hepatol. 2017 Feb;15(2):166-174. doi: 10.1016/j.cgh.2016.10.024.
4
Older people and inflammatory bowel disease: a systematic review.老年人与炎症性肠病：一项系统综述
J Clin Nurs. 2008 Nov;17(11c):400-6. doi: 10.1111/j.1365-2702.2008.02577.x.
5
[Analysis of work productivity and quality of life in patients with inflammatory bowel disease].[炎症性肠病患者的工作效率和生活质量分析]
Orv Hetil. 2023 Dec 17;164(50):1974-1984. doi: 10.1556/650.2023.32917.
6
Role of the Dietitian in the Inflammatory Bowel Disease Multidisciplinary Team.营养师在炎症性肠病多学科团队中的作用。
J Gastroenterol Hepatol. 2025 Sep;40(9):2190-2196. doi: 10.1111/jgh.70001. Epub 2025 Jul 10.
7
Watch and Wait for rectal cancer in inflammatory bowel disease.观察和等待炎症性肠病中的直肠癌。
BMJ Case Rep. 2023 Jul 10;16(7):e252562. doi: 10.1136/bcr-2022-252562.
8
Acute and Late Bowel Toxicity in Radiotherapy Patients with Inflammatory Bowel Disease: A Systematic Review.炎症性肠病放疗患者的急性和晚期肠道毒性：一项系统评价
Clin Oncol (R Coll Radiol). 2015 Sep;27(9):536-41. doi: 10.1016/j.clon.2015.05.001. Epub 2015 May 26.
9
Safety and potential interaction of immunosuppressive drugs for the treatment of inflammatory bowel disease in elderly patients.老年炎症性肠病患者治疗中免疫抑制剂的安全性和潜在相互作用。
Minerva Gastroenterol (Torino). 2024 Mar;70(1):98-108. doi: 10.23736/S2724-5985.21.02919-3. Epub 2021 May 31.
10
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.21 世纪全球炎症性肠病的发病率和流行率：基于人群的系统综述研究。
Lancet. 2017 Dec 23;390(10114):2769-2778. doi: 10.1016/S0140-6736(17)32448-0. Epub 2017 Oct 16.
引用本文的文献
1
Recent advances in gastroenterology.胃肠病学的最新进展。
Singapore Med J. 2025 Aug 1;66(8):412. doi: 10.4103/singaporemedj.SMJ-2025-170. Epub 2025 Aug 20.
本文引用的文献
1
Artificial Intelligence-Driven Personalized Medicine: Transforming Clinical Practice in Inflammatory Bowel Disease.人工智能驱动的个性化医疗：改变炎症性肠病的临床实践
Gastroenterology. 2025 Mar 10. doi: 10.1053/j.gastro.2025.03.005.
2
Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review.人工智能将彻底改变炎症性肠病临床试验：全面综述。
Therap Adv Gastroenterol. 2025 Feb 23;18:17562848251321915. doi: 10.1177/17562848251321915. eCollection 2025.
3
Modifiable Psychological Factors are Associated With Clusters of Pain, Fatigue, Fecal Incontinence, and Irritable Bowel Syndrome-Type Symptoms in Inflammatory Bowel Disease: A Latent Profile Analysis.可改变的心理因素与炎症性肠病中的疼痛、疲劳、大便失禁和肠易激综合征样症状群相关：一项潜在类别分析
J Crohns Colitis. 2025 May 8;19(5). doi: 10.1093/ecco-jcc/jjae183.
4
Efficacy and safety of Advanced Combination Treatment in immune-mediated inflammatory disease: A systematic review and meta-analysis of randomized controlled trials.免疫介导性炎症疾病中高级联合治疗的疗效与安全性：一项随机对照试验的系统评价和荟萃分析
J Autoimmun. 2024 Dec;149:103331. doi: 10.1016/j.jaut.2024.103331. Epub 2024 Nov 6.
5
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease.抗肿瘤坏死因子治疗炎症性肠病的纵向单细胞图谱。
Nat Immunol. 2024 Nov;25(11):2152-2165. doi: 10.1038/s41590-024-01994-8. Epub 2024 Oct 22.
6
Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.抗白细胞介素-10 的中和自身抗体治疗炎症性肠病。
N Engl J Med. 2024 Aug 1;391(5):434-441. doi: 10.1056/NEJMoa2312302.
7
A disease-associated gene desert directs macrophage inflammation through ETS2.一种疾病相关的基因荒漠通过 ETS2 指导巨噬细胞炎症。
Nature. 2024 Jun;630(8016):447-456. doi: 10.1038/s41586-024-07501-1. Epub 2024 Jun 5.
8
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.一种生物标志物分层比较新诊断克罗恩病患者自上而下与加速阶梯治疗策略的效果（PROFILE）：一项多中心、开放标签随机对照试验。
Lancet Gastroenterol Hepatol. 2024 May;9(5):415-427. doi: 10.1016/S2468-1253(24)00034-7. Epub 2024 Feb 22.
9
AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.AGA 临床实践更新：炎症性肠病患者的饮食和营养治疗：专家综述。
Gastroenterology. 2024 Mar;166(3):521-532. doi: 10.1053/j.gastro.2023.11.303. Epub 2024 Jan 23.
10
Efficacy and Safety of Advanced Oral Small Molecules for Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.高级口服小分子药物治疗炎症性肠病的疗效和安全性：系统评价和荟萃分析。
J Crohns Colitis. 2023 Nov 24;17(11):1800-1816. doi: 10.1093/ecco-jcc/jjad100.
Zotero 插件